5/14
07:08 am
zntl
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit [Yahoo! Finance]
Low
Report
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit [Yahoo! Finance]
5/14
07:00 am
zntl
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
Low
Report
Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
5/8
03:33 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at HC Wainwright from $46.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at HC Wainwright from $46.00 to $40.00. They now have a "buy" rating on the stock.
5/8
10:09 am
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Stifel Nicolaus from $36.00 to $32.00. They now have a "buy" rating on the stock.
Low
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target lowered by analysts at Stifel Nicolaus from $36.00 to $32.00. They now have a "buy" rating on the stock.
5/8
07:46 am
zntl
Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock [Yahoo! Finance]
Medium
Report
Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock [Yahoo! Finance]
5/7
07:00 am
zntl
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
Medium
Report
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
5/1
05:30 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2
04:17 pm
zntl
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024 [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024 [Yahoo! Finance]
4/2
04:05 pm
zntl
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
Medium
Report
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
4/1
05:30 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/20
10:05 am
zntl
Susan G. Komen® Strengthens Leadership with Strategic Appointments to Board of Directors [Yahoo! Finance]
Low
Report
Susan G. Komen® Strengthens Leadership with Strategic Appointments to Board of Directors [Yahoo! Finance]
3/1
06:00 pm
zntl
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/29
06:06 am
zntl
Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price [Yahoo! Finance]
Low
Report
Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price [Yahoo! Finance]
2/28
01:10 pm
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
Medium
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $46.00 price target on the stock.
2/28
11:25 am
zntl
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet [Yahoo! Finance]
High
Report
Wall Street Analysts Think Zentalis Pharmaceuticals, Inc. (ZNTL) Could Surge 136.44%: Read This Before Placing a Bet [Yahoo! Finance]
2/28
08:17 am
zntl
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target raised by analysts at Wedbush from $12.00 to $15.00. They now have a "neutral" rating on the stock.
Medium
Report
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) had its price target raised by analysts at Wedbush from $12.00 to $15.00. They now have a "neutral" rating on the stock.
2/28
07:00 am
zntl
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Medium
Report
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
2/27
07:13 pm
zntl
Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ... [Yahoo! Finance]
Medium
Report
Zentalis Pharmaceuticals Inc (ZNTL) Reports Full Year 2023 Financial Results and Provides ... [Yahoo! Finance]
2/27
07:00 am
zntl
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
Medium
Report
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates